Obicetrapib
Obicetrapib is a CETP inhibitor that is intended to treat dyslipidemia.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Obicetrapib is a CETP inhibitor that is intended to treat dyslipidemia. Obicetrapib is a lipid-modifying agent that blocks a blood protein called CETP, thereby lowering the level of LDL cholesterol. The most common side effects include hypertension, dizziness, headache, diarrhea, and abdominal pain.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377022457 under CC BY-SA 4.0; modifications have been made.